158 related articles for article (PubMed ID: 8631886)
21. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
23. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
He Y; Rothnagel JA; Epis MR; Leedman PJ; Smith R
Mol Carcinog; 2009 Feb; 48(2):167-79. PubMed ID: 18680105
[TBL] [Abstract][Full Text] [Related]
24. HnRNP A2/B1 proteins in nontumorous alveolar cells.
Satoh H; Ishikawa H; Kamma H; Yamashita YT; Sekizawa K
Lung; 2003; 181(4):219-25. PubMed ID: 14692562
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms.
Kamma H; Horiguchi H; Wan L; Matsui M; Fujiwara M; Fujimoto M; Yazawa T; Dreyfuss G
Exp Cell Res; 1999 Feb; 246(2):399-411. PubMed ID: 9925756
[TBL] [Abstract][Full Text] [Related]
26. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts.
Burd CG; Swanson MS; Görlach M; Dreyfuss G
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9788-92. PubMed ID: 2557628
[TBL] [Abstract][Full Text] [Related]
27. Expression and effect of heterogeneous nuclear ribonucleoprotein A2/B1 in tongue squamous cell carcinoma.
Liu Y; Shen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):633-640. PubMed ID: 37539565
[TBL] [Abstract][Full Text] [Related]
28. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.
Wu S; Sato M; Endo C; Sakurada A; Dong B; Aikawa H; Chen Y; Okada Y; Matsumura Y; Sueoka E; Kondo T
Lung Cancer; 2003 Aug; 41(2):179-86. PubMed ID: 12871781
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle.
Kamma H; Satoh H; Matusi M; Wu WW; Fujiwara M; Horiguchi H
Immunol Lett; 2001 Feb; 76(1):49-54. PubMed ID: 11222913
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
31. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
[TBL] [Abstract][Full Text] [Related]
32. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
Man YG; Martinez A; Avis IM; Hong SH; Cuttitta F; Venzon DJ; Mulshine JL
Am J Respir Cell Mol Biol; 2000 Nov; 23(5):636-45. PubMed ID: 11062142
[TBL] [Abstract][Full Text] [Related]
33. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
Tominaga M; Sueoka N; Irie K; Iwanaga K; Tokunaga O; Hayashi S; Nakachi K; Sueoka E
Lung Cancer; 2003 Apr; 40(1):45-53. PubMed ID: 12660006
[TBL] [Abstract][Full Text] [Related]
34. Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene.
Roshon M; DeGregori JV; Ruley HE
BMC Genomics; 2003 Jan; 4(1):2. PubMed ID: 12546712
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.
Sato A; Sueoka-Aragane N; Saitoh J; Komiya K; Hisatomi T; Tomimasu R; Hayashi S; Sueoka E
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1191-7. PubMed ID: 18461365
[TBL] [Abstract][Full Text] [Related]
36. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
[TBL] [Abstract][Full Text] [Related]
38. Purification and nucleic acid binding properties of a fragment of type C1/C2 heterogeneous nuclear ribonucleoprotein from thymic nuclear extracts.
Amrute SB; Abdul-Manan Z; Pandey V; Williams KR; Modak MJ
Biochemistry; 1994 Jul; 33(27):8282-91. PubMed ID: 7518245
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein.
Ma AS; Moran-Jones K; Shan J; Munro TP; Snee MJ; Hoek KS; Smith R
J Biol Chem; 2002 May; 277(20):18010-20. PubMed ID: 11886857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
